‘Pay-For-Delay’ Deals Likely Put On Hold Themselves After Cipro Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
California Supreme Court finds patents are ‘probablistic rather than ironclad,’ and outlines four-prong antitrust test that further complicates brand/generic deal making.